MedPage Today on MSN
Antioxidant may influence brain changes in multiple sclerosis, study suggests
N-acetylcysteine linked to functional connectivity, cerebral glucose metabolism ...
A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than ...
In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...
Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.
The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has been increasingly connected to human health and disease. A new Yale study ...
BUFFALO, N.Y. — A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on ...
In newly diagnosed MS patients, B-cell-depleting and high-efficacy therapies reduced relapses more than oral treatments. Changes in 2-year disability scores were similar across treatment groups, ...
A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on health-related quality of life, with findings that could reshape how services ...
A 2-sample Mendelian randomization study found a potential connection between dietary intake and multiple sclerosis (MS) risk and severity. According to the National Multiple Sclerosis Society, diet ...
TG Therapeutics TGTX has announced positive top-line data from the late-stage ENHANCE study, which evaluated a consolidated single-infusion regimen of its sole marketed drug, Briumvi (ublituximab-xiiy ...
Elevated EBNA-1 peptide antibody titers were substantially more prevalent in RRMS than in MOGAD, NMOSD, other inflammatory neurologic diseases, other neurologic diseases, or healthy controls.
Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results